Utility values and its time to deterioration in breast cancer patients after diagnosis and during treatments.
Fiche publication
Date publication
mai 2022
Journal
Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation
Auteurs
Membres identifiés du Cancéropôle Est :
Pr CONROY Thierry, Dr DABAKUYO-YONLI Sandrine, Pr GRAESSLIN Olivier, Pr GUILLEMIN Francis, Pr JOLLY Damien, Pr NERICH Virginie, Pr VELTEN Michel
Tous les auteurs :
Haidari RE, Anota A, Dabakuyo-Yonli TS, Guillemin F, Conroy T, Velten M, Jolly D, Causeret S, Cuisenier J, Graesslin O, Abbas LA, Nerich V
Lien Pubmed
Résumé
The potential effects of breast cancer (BC) on health-related quality of life (HRQoL) should be considered in clinical and policy decision-making, as the economic burden of BC management is currently assessed. In the last decades, time-to-HRQoL score deterioration (TTD) has been proposed as an approach to the analysis of longitudinal HRQoL in oncology. The main objectives of the current study were to investigate the evolution of the utility values in BC patients after diagnosis and during follow-ups and to evaluate the TTD in utility values among women in all stages of BC.
Mots clés
Breast cancer, Health-state utility values, Time to deterioration
Référence
Qual Life Res. 2022 05 19;: